| 000 | 01645 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517011328.0 | ||
| 264 | 0 | _c20150320 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1479-683X | ||
| 024 | 7 |
_a10.1530/EJE-14-0586 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Caenegem, E | |
| 245 | 0 | 0 |
_aBody composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI). _h[electronic resource] |
| 260 |
_bEuropean journal of endocrinology _cFeb 2015 |
||
| 300 |
_a163-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle Strength _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTestosterone _xadministration & dosage |
| 650 | 0 | 4 | _aTransgender Persons |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWierckx, K | |
| 700 | 1 | _aTaes, Y | |
| 700 | 1 | _aSchreiner, T | |
| 700 | 1 | _aVandewalle, S | |
| 700 | 1 | _aToye, K | |
| 700 | 1 | _aLapauw, B | |
| 700 | 1 | _aKaufman, J-M | |
| 700 | 1 | _aT'Sjoen, G | |
| 773 | 0 |
_tEuropean journal of endocrinology _gvol. 172 _gno. 2 _gp. 163-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/EJE-14-0586 _zAvailable from publisher's website |
| 999 |
_c24497787 _d24497787 |
||